{"originalText": "患者于2004年4月份在本院行右乳癌改良根治术,术后病理诊为:右乳腺浸润性导管癌,淋巴结10/11(+),PT3N3M0,IIIC期,ER(+),PR(-),HER-2(-),KI67(+++).术后以FEC方案化疗4程,之后行放疗.2004年9月份开始行TAM治疗,2004年12月加用雷诺得,2007年9月行卵巢去势手术,改瑞宁得治疗.2010年4月份发现骨转移(右股骨代谢活跃)行右股骨姑息性放疗.2011年初发现肺肝淋巴结等转移,行多西他赛化疗程4程后评价PD,改GX2程,肝病灶PD,行NP方案化疗6程,评价SD.后于2012年5月始使用替加氟治疗.复查CT示肝转移灶进展(2012年5月11日肝脏数个低密度灶4×4MM-9×9MM,2012年9月21肝数个低密度灶最大33×24MM).于2012-10-22以“泰素+顺铂”方案化疗一程。为进一步治疗入院.精神,睡眠,食欲欠佳,大小便正常.体重无明显变化.。", "entities": [{"end_pos": 23, "label_type": "手术", "overlap": 0, "start_pos": 15}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 31, "end_pos": 40}, {"end_pos": 147, "label_type": "药物", "overlap": 0, "start_pos": 144}, {"end_pos": 162, "label_type": "手术", "overlap": 0, "start_pos": 156}, {"end_pos": 167, "label_type": "药物", "overlap": 0, "start_pos": 164}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 180, "end_pos": 183}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"end_pos": 196, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"end_pos": 211, "label_type": "解剖部位", "overlap": 0, "start_pos": 210}, {"end_pos": 212, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"end_pos": 224, "label_type": "药物", "overlap": 0, "start_pos": 220}, {"end_pos": 242, "label_type": "解剖部位", "overlap": 0, "start_pos": 241}, {"end_pos": 277, "label_type": "药物", "overlap": 0, "start_pos": 274}, {"label_type": "影像检查", "overlap": 0, "start_pos": 282, "end_pos": 284}, {"end_pos": 286, "label_type": "解剖部位", "overlap": 0, "start_pos": 285}, {"end_pos": 304, "label_type": "解剖部位", "overlap": 0, "start_pos": 302}, {"end_pos": 332, "label_type": "解剖部位", "overlap": 0, "start_pos": 331}, {"end_pos": 364, "label_type": "药物", "overlap": 0, "start_pos": 362}, {"end_pos": 367, "label_type": "药物", "overlap": 0, "start_pos": 365}]}
